Courtney Stanley, PA
Physician Assistant · Lake City, SCNPI 1205095809
Payments from drug & device makers
Across 321 payments — averaging $15.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$959
- AstraZeneca$551
- Novo Nordisk$448
- Bayer$278
- Amgen$198
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$191
- plus $2K from 33 others
What the payments were for
- Food & beverage$4,908100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 75 | $959 |
| AstraZeneca(2 entities) | 36 | $551 |
| Novo Nordisk | 29 | $448 |
| Bayer | 19 | $278 |
| Amgen(2 entities) | 12 | $198 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $191 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $185 |
| GSK | 10 | $180 |
| Boehringer Ingelheim | 10 | $176 |
| Exact Sciences | 11 | $173 |
| Novartis | 10 | $147 |
| Johnson & Johnson | 9 | $135 |
| Pfizer | 8 | $130 |
| Forte Bio-pharma LLC | 8 | $127 |
| Esperion Therapeutics, Inc. | 6 | $117 |
| Biohaven Pharmaceuticals, Inc. | 6 | $111 |
| Antares Pharma, Inc. | 6 | $109 |
| Sumitomo Pharma America, Inc. | 4 | $80 |
| Lilly USA, LLC | 5 | $73 |
| Nevro Corp. | 3 | $64 |
| Amarin Pharma, Inc. | 4 | $57 |
| Xeris Pharmaceuticals, Inc. | 3 | $55 |
| Sanofi-aventis U.S. LLC | 3 | $53 |
| Ardelyx, Inc. | 2 | $36 |
| Astellas Pharma US Inc | 2 | $26 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $25 |
| Vital Connect, Inc | 1 | $24 |
| Viatris Specialty LLC | 1 | $24 |
| Sunovion Pharmaceuticals Inc. | 1 | $21 |
| Verity Pharmaceuticals Inc. | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Abbott | 1 | $18 |
| Tolmar, Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Corcept Therapeutics | 1 | $14 |
| Shield Therapeutics Inc | 1 | $14 |
| Eisai Inc. | 1 | $14 |
| Mylan Specialty L.p. | 1 | $12 |
| Phathom Pharmaceuticals, Inc. | 2 | $12 |
How this compares
$4,908 in reported general payments places this provider in the 90th percentile of 1,852 physician assistant providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 27 | $34,493 |
| JardianceEmpagliflozin | 28 | $32,420 |
| LinzessLinaclotide | 14 | $13,223 |
| TrintellixVortioxetine Hydrobromide | 11 | $5,147 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $3,056 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 71 | $2,755 |
| Atorvastatin Calcium | 160 | $1,759 |
| SynthroidLevothyroxine Sodium | 25 | $1,552 |
| Fluticasone Propionate | 87 | $1,508 |
| Omeprazole | 76 | $1,428 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 25 | $1,168 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $1,117 |
| Bupropion XlBupropion Hcl | 28 | $972 |
| Losartan Potassium | 91 | $920 |
| Montelukast Sodium | 72 | $881 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $448 | $34,49327 claims |
| Boehringer IngelheimJardiance | $176 | $32,42028 claims |
| AbbVieLinzess, Synthroid | $959 | $14,77539 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $185 | $5,14711 claims |
| AstraZenecaSymbicort | $551 | $3,05613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,852 physician assistant providers in South Carolina.
Other physician assistant in Lake City
- Benjamin AddyWest Columbia$377K
- Michael OvercashCharleston$210K
- Allison LesterMt Pleasant$163K
- Nicole KeeterFort Mill$129K
- William YoungGreenville$117K
- Stephanie DavisAnderson$78K
- Vicki RobertsWest Columbia$77K
- Eric ShoupColumbia$74K
- Lauren OlsonNorth Charleston$62K
- Martha GreenSummerville$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.